Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)

References

• Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995;311:158–61.
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008;28:386–95.
   PubMed Web of Science ®Google Scholar
• Ong IP, Pitts A, Younossi ZM. Increased mortality and liver-related mortality in patients with nonalcoholic fatty liver disease. J Hepatol 2008;49:608–12.
   PubMed Web of Science ®Google Scholar
• Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27–41.
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. J Am Med Assoc 2002;287:356–9.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917–23.
   PubMed Web of Science ®Google Scholar
• Farrell GC, Chitturi S, Lau GK, Sollano JD, Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region. Gastroenterol Hepatol 2007;22:775–7.
   Google Scholar
• Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:339–50.
   PubMed Web of Science ®Google Scholar
• Collantes RS, Ong JP, Younossi ZM. The metabolic syndrome and nonalcoholic fatty liver disease. Panminerva Medica 2006;48:41–8.
   PubMed Web of Science ®Google Scholar
• Nugent C, Younossi ZM. Evaluation and management of obesity-related non-alcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2007;14:432–41.
   Google Scholar
• Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002;35:746–52.
   PubMed Web of Science ®Google Scholar
• Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17–26.
   PubMed Web of Science ®Google Scholar
• Bondini S, Kleiner DE, Goodman Z, Gramlich T, Younossi ZM. Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis 2007;11:17–23.
   PubMedGoogle Scholar
• Kim CH, Younossi ZM. Non-alcoholic fatty liver disease. Cleveland Clinic J Med 2008;75:673–80.
   Web of Science ®Google Scholar
• Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1–16.
   PubMedGoogle Scholar
• Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15:310–15.
   PubMed Web of Science ®Google Scholar
• Rafiq N, Younossi ZM. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin Liver Dis 2009;13:249–66.
   PubMed Web of Science ®Google Scholar
• Kandaraki E, Chirstakou C, Diamanti-Kandarakis E. Metabolic syndrome and polycystic ovary syndrome… and vice versa. Arq Bras Endocrinol Metabol 2009;53:227–37.
   PubMedGoogle Scholar
• Ramos R, Olden K. The prevalence of metabolic syndrome among US women of child bearing age. Am J Public Health 2008;98:1122–7.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007;4(Suppl B):S162–77.
   Google Scholar
• Angioni S, Portoghese E, Milano F, Melis GB, Fulghesu AM. Diagnosis of metabolic disorders in women with polycystic ovary syndrome. Obstet Gynecol Survey 2008;63:796–802.
   PubMed Web of Science ®Google Scholar
• Brzozowska MM, Ostapowicz G, Weltman MD. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Hepatology 2009;24:243–7.
   Web of Science ®Google Scholar
• Mason H, Colao A, Blume-Peytavi U, Rice S, Qureshi A, Pellatt L, Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review. Clin Endocrinol 2008;69:831–44.
   PubMed Web of Science ®Google Scholar
• Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1741–7.
   PubMed Web of Science ®Google Scholar
• Cerda C, Perez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007;47:412–17.
   PubMed Web of Science ®Google Scholar
• Zheng RH, Ding CF. Prevalence of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome: a case–control study. Zhonghua Fu Chan Ke Za Zhi 2008;43:98–101.
   PubMedGoogle Scholar
• Gambarin-Gelwan M, Kinkhabwala SV, Shiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007;5:496–501.
   PubMed Web of Science ®Google Scholar
• Stepanova M, Aquino, Alsheddi A, Gupta R, Fang Y, Younossi ZM. Clinical predictors of fibrosis in patients with chronic liver disease. Aliment Pharmacol Ther 2010;31:1085–94.
   PubMed Web of Science ®Google Scholar
• Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Goodman Z, Younossi ZM. Independent predictors of fibrosis in patients with non-alcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:1224–9.
   PubMed Web of Science ®Google Scholar